MMVF Twitter
Financing Solutions that Fit

News for Life Sciences sector

TORONTO, ONTARIO – Monday, March 07, 2005– Axela Biosensors Inc., a leading developer of biosensor technology, today announced that it has secured over CDN$6 million in additional funding. The financi... >>
Burlington , Vermont , U.S.A.  – February 4, 2005 – Triosyn Corp., a world leader in antimicrobial technology, has secured $2.0 million in venture financing from MMV Financial Inc. Triosyn Corp. is a... >>
WINNIPEG, MANITOBA – November 16, 2004 – Momentum Healthware, the Canadian leader in assessment-based clinical software, has secured a CDN$2.1MM venture loan from MMV Financial Inc. Momentum Healthwa... >>
MILWAUKEE and TORONTO -- GE Medical Systems Information Technologies, the healthcare IT business of General Electric Company (NYSE: GE), and Triple G(R) Systems Group, Inc. (TSX: TGG), announced today... >>
MONTREAL -- Galileo's proprietary platform is designed for the identification of genes associated with common and economically important diseases and the rapid production of high quality targets f... >>
Montreal, Canada -- Qbiogene Inc., a fully integrated provider of molecular and cellular biology drug discovery and development research products and services, has secured a US$3.0MM venture loan ... >>
Cubist Pharmaceuticals Inc. yesterday said it will acquire TerraGen Discovery Inc. for $29 million in a stock swap that will give Cubist proprietary technology for developing antibiotics using untappe... >>
Toronto -- The GATX/MM Venture Finance Partnership ("the Partnership") is pleased to announce that it has completed a $2.0MM venture loan financing with Triple G Systems Group, Inc. ("Triple G"). ... >>
CALGARY, ALBERTA -- SYNSORB Biotech Inc. (SYNSORB) today announced that the Company has completed and received funding under a $3.0 million term loan, with principal and interest repayable monthly... >>
Page 3 of 3First   Previous   1  2  [3]  Next   Last   

MMV :: 370 King Street West, Suite 442 Toronto ON M5V 1J9 Canada